Clinical Trial Update: The Immunotherapy of Nasopharyngeal Cancer Using Cancer Stem Cells Vaccine [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update on immunotherapy for nasopharyngeal cancer using a cancer stem cell vaccine (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Cancer

Drugs mentioned

• Cancer stem cell vaccine (immunotherapy)

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Neoplasms, Lung | Phase 1, Phase 2 | Status: COMPLETED